InTouch Newsletter Issue 9

Congresses and Events

PCR London Valves Symposia: Extending treatment options to address evolving needs in TAVI

PCR London Valves Symposia
Advances in device technology can expand treatment options for transcatheter valve implantation from vascular access to cerebral embolic protection. Watch this symposia from PCR London Valves to understand how the ACURATE neo™ and LOTUS valves combined with high profile accessories can advance practice in key patient subsets.

Moving to a patient tailored TAVI: Dr Van Mieghem’s interview from PCR London Valves

Moving to a patient tailored TAVI
In this interview from PCR London Valves, Dr. Nicolas Van Mieghem (Erasmus Medical Center, Netherlands) discusses Boston Scientific offering and the importance of having 2 different valves types to help you delivering optimal TAVI results for patients.

Sentinel Cerebral Embolic Protection System, now Part of Boston Scientific´s TAVI Portfolio

Sentinel Cerebral Embolic Protection System
The SENTINEL cerebral protection system has demonstrated that reduces the risk of stroke during TAVI in the range of 63 – 78%. It is the only TAVI cerebral protection device commercially available and, to date, it has protected over 11,000 patients. See the symposia from PCR London Valves to learn more about the real-world European experience of cerebral protection.

SYNERGY™ - High-bleeding risk patients and DAPT: implementing the latest clinical evidence into real-world practice

Synergy at PCR
A symposium from EuroPCR 2018 dedicated to the latest clinical data and recent evidence updates, to understand how to relate trial data into real practice. Watch the video and learn more about the potential benefits of bioabsorbable polymer DES in high-bleeding risk patients, the SYNERGY™ design and ongoing DAPT studies.

Educational Corner

PCR webinar: The new rotational atherectomy system for treating undilatable coronary lesions

Dr. A. de Belder, Dr B. Farah, Dr S. Doshi
Dr. A. de Belder, Dr B. Farah, Dr S. Doshi
A 60-minute live discussion between leading experts about the new rotational atherectomy equipment.
Attend this PCR webinar to discover how to avoid and manage most common complications and learn more about the European Consensus Document, the "new rules" and the procedural recommendations.

WATCHMAN™ in shallow anatomies: a case with Prof Bergmann

Watchman Case Example
Prof Bergmann presents a WATCHMANTM case in a very shallow anatomy. He explains that the right technique can lead to successful outcomes, even in challenging anatomies. Watch the video to learn more.

InCathlab Live Case: Challenges of PCI and DAPT in an elderly patient with ASA allergy

A PCI live case performed by  Dr Avran and Dr Sideris from Tzanck Institute (Saint-Laurent du Var, France) on an elderly patient at high bleeding risk and ASA allergy with previous PCI.

SAFARI²™ - #1 TAVI Wire in Europe

Prof. Meredith

As part of Boston Scientific’s TAVI portfolio, the SAFARI2™ is a pre-shaped TAVI guidewire designed for predictable, reliable performance across a broad spectrum of transcatheter devices. *,†, ‡,§,**

" SAFARI gave us a lot more forgiveness and I think it really protected the patients." Listen to Dr. Meduri, Co-Medical Director, Marcus Heart Valve Center, as he shares his experiences with SAFARI2™.

Clinical Studies

FAME 2 Study: Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

Presented during EuroPCR 2018, the final 5-year FAME 2 analysis shows continued benefit for percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) over medical therapy in stable coronary artery disease (CAD), but also a new signal for fewer myocardial infarctions (MIs) among those treated with stents.

EVOLVE II & SENIOR Trial Data Continues to Impress. Prof Meredith discusses the results

The collective body of clinical evidence continues to demonstrate best-in-class healing with the SYNERGY™ BP Stent. Watch Prof. Ian Meredith, EVP and Global Chief Medical Officer for Boston Scientific, and other global KOLs discuss the 4-year results of the EVOLVE II Trial and recent evidence on short DAPT from the SENIOR Trial.

Bench testing performed by Boston Scientific. Bench test results may not necessarily be indicative of clinical performance. Data on file.

* Curve Retention test data with SAFARI2 Extra Small, Confida™ Brecker, Amplatz Extra Stiff™, and Amplatz Super Stiff™ Guidewires (n = 1).
† Guidewire Compression test data with SAFARI2 Extra Small, Confida Brecker, Amplatz Extra Stiff, and Amplatz Super Stiff Guidewires (n = 1).
‡ Nosecone Tracking test data with SAFARI2 Extra Small, Confida Brecker, Amplatz Extra Stiff, and Amplatz Super Stiff Guidewires (n = 1).
§ Simulated Use Static Friction, Dynamic Friction, and Distal Curve Displacement test data with Lotus™ Valve System with Safari Large and Amplatz Super Stiff Guidewires (n = 4).
** Simulated Use Friction, Dynamic Friction, and Distal Curve Displacement with Evolut® R with SAFARI2 Extra Small and Confida Brecker Guidewires (n = 3).
The Safari™ Guidewire is manufactured by Lake Region Medical and distributed by Boston Scientific Corporation.
All cited trademarks are the property of their respective owners. CAUTION: Federal (U.S.) law restricts this device to sale by or on the order of a physician.

Further Information